Tachykinin peptides

Overview

Structure of a tachykinin peptide.

Tachykinin peptides are a family of neuropeptides that share a common C-terminal sequence and are involved in a variety of physiological processes. These peptides are characterized by their ability to rapidly induce contraction of smooth muscle tissues, hence the name "tachykinin," derived from the Greek words "tachys" (swift) and "kinein" (to move).

Structure

Tachykinins are small peptides, typically consisting of 10-12 amino acids. The defining feature of tachykinins is their conserved C-terminal sequence, which is -Phe-X-Gly-Leu-Met-NH2, where "X" can be various amino acids. This sequence is crucial for their biological activity and interaction with neurokinin receptors.

Function

Tachykinins are involved in numerous physiological functions, including:

• Neurotransmission: They act as neurotransmitters in the central nervous system and peripheral nervous system.
• Smooth muscle contraction: They induce contraction in smooth muscles, such as those found in the gastrointestinal tract and respiratory system.
• Pain perception: Tachykinins are involved in the transmission of pain signals.
• Inflammatory responses: They play a role in modulating inflammation and immune responses.

Types of Tachykinins

The most well-known tachykinins include:

• Substance P: Involved in pain perception and inflammatory processes.
• Neurokinin A: Primarily found in the gastrointestinal tract and involved in smooth muscle contraction.
• Neurokinin B: Plays a role in reproductive system regulation and endocrine system function.

Receptors

Tachykinins exert their effects by binding to specific G protein-coupled receptors known as neurokinin receptors. There are three main types of neurokinin receptors:

• NK1 receptor: Has a high affinity for Substance P.
• NK2 receptor: Preferentially binds Neurokinin A.
• NK3 receptor: Primarily interacts with Neurokinin B.

Clinical Significance

Tachykinins and their receptors are targets for therapeutic interventions in various conditions, such as:

• Chronic pain: Antagonists of the NK1 receptor are used to manage pain.
• Asthma and COPD: Tachykinin receptor antagonists can help reduce bronchoconstriction.
• Depression and anxiety: NK1 receptor antagonists are being explored for their potential antidepressant and anxiolytic effects.

Related pages

• Neuropeptide
• Neurotransmitter
• G protein-coupled receptor
• Substance P